サマリー

ガラス基板の世界市場 2022-2026
Technavioはガラス基板市場を監視しており、2022-2026年の間に6億1614万ドルの成長が見込まれ、予測期間中にCAGR 5.92%で加速しています。当レポートでは、ガラス基板市場の全体分析、市場規模・予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、自動車におけるガラス繊維複合材料の採用拡大、航空宇宙・防衛用途でのガラス基板の使用増加、家電製品の需要急増によって牽引されています。
ガラス基板市場の分析には、エンドユーザーセグメントと地理的な状況も含まれます。
Technavioのガラス基板市場は以下のようにセグメント化されています。
エンドユーザー別
- エレクトロニクス
- 自動車
- 医療用
- 太陽電池
- 航空宇宙・防衛
地域別構成比
- APAC
- 北アメリカ
- 欧州
- 南米
- 中東・アフリカ
本調査では、今後数年間におけるガラス基板市場の成長を促進する主な要因の一つとして、太陽光発電プラントにおけるガラス基板の採用を挙げています。また、様々なエンドユーザー産業の成長と拡大、電気・電子産業におけるアプリケーションの急増は、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ガラス基板市場に関する弊社のレポートは、以下の分野を対象としています。
- ガラス基板市場のサイジング
- ガラス基板市場の予測
- ガラス基板市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AGC Inc.、Apogee Enterprises Inc、Corning Inc、DuPont de Nemours Inc、HOYA Corp.、IRICO Group New Energy Co.Ltd.、Kyodo International Inc.、Laseroptik GmbH、MTI Corp.、日本板硝子(株)、NOVA Electronic Materials LLC.(株)オハラ、Otto Chemie Pvt. Ltd., Plan Optik AG, SCHOTT AG, Shilpa Enterprises, Shin Etsu Chemical Co.Ltd.、Solaronix SA、Techinstro Industries、Vedanta Ltd.の7社です。また、ガラス基板市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/glass-substrate-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、広範な一次および二次調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Pharmaceuticals - Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
o 5.4 Diagnostics - Market size and forecast 2021-2026
o Exhibit 32: Chart on Diagnostics - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Diagnostics - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Diagnostics - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Diagnostics - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Bayer AG
o Exhibit 85: Bayer AG - Overview
o Exhibit 86: Bayer AG - Business segments
o Exhibit 87: Bayer AG - Key offerings
o Exhibit 88: Bayer AG - Segment focus
o 10.4 C. H. Boehringer Sohn AG and Co. KG
o Exhibit 89: C. H. Boehringer Sohn AG and Co. KG - Overview
o Exhibit 90: C. H. Boehringer Sohn AG and Co. KG - Business segments
o Exhibit 91: C. H. Boehringer Sohn AG and Co. KG - Key news
o Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
o Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
o 10.5 Ceva Sante Animale
o Exhibit 94: Ceva Sante Animale - Overview
o Exhibit 95: Ceva Sante Animale - Product / Service
o Exhibit 96: Ceva Sante Animale - Key offerings
o 10.6 Dechra Pharmaceuticals Plc
o Exhibit 97: Dechra Pharmaceuticals Plc - Overview
o Exhibit 98: Dechra Pharmaceuticals Plc - Business segments
o Exhibit 99: Dechra Pharmaceuticals Plc - Key offerings
o Exhibit 100: Dechra Pharmaceuticals Plc - Segment focus
o 10.7 Heska Corp.
o Exhibit 101: Heska Corp. - Overview
o Exhibit 102: Heska Corp. - Business segments
o Exhibit 103: Heska Corp. - Key news
o Exhibit 104: Heska Corp. - Key offerings
o Exhibit 105: Heska Corp. - Segment focus
o 10.8 IDEXX Laboratories Inc.
o Exhibit 106: IDEXX Laboratories Inc. - Overview
o Exhibit 107: IDEXX Laboratories Inc. - Business segments
o Exhibit 108: IDEXX Laboratories Inc. - Key news
o Exhibit 109: IDEXX Laboratories Inc. - Key offerings
o Exhibit 110: IDEXX Laboratories Inc. - Segment focus
o 10.9 Indian Immunologicals Ltd.
o Exhibit 111: Indian Immunologicals Ltd. - Overview
o Exhibit 112: Indian Immunologicals Ltd. - Product / Service
o Exhibit 113: Indian Immunologicals Ltd. - Key offerings
o 10.10 Merck and Co. Inc.
o Exhibit 114: Merck and Co. Inc. - Overview
o Exhibit 115: Merck and Co. Inc. - Business segments
o Exhibit 116: Merck and Co. Inc. - Key news
o Exhibit 117: Merck and Co. Inc. - Key offerings
o Exhibit 118: Merck and Co. Inc. - Segment focus
o 10.11 Virbac Group
o Exhibit 119: Virbac Group - Overview
o Exhibit 120: Virbac Group - Business segments
o Exhibit 121: Virbac Group - Key news
o Exhibit 122: Virbac Group - Key offerings
o Exhibit 123: Virbac Group - Segment focus
o 10.12 Zoetis Inc.
o Exhibit 124: Zoetis Inc. - Overview
o Exhibit 125: Zoetis Inc. - Business segments
o Exhibit 126: Zoetis Inc. - Key news
o Exhibit 127: Zoetis Inc. - Key offerings
o Exhibit 128: Zoetis Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 129: Inclusions checklist
o Exhibit 130: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 131: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 132: Research methodology
o Exhibit 133: Validation techniques employed for market sizing
o Exhibit 134: Information sources
o 11.5 List of abbreviations
o Exhibit 135: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Diagnostics - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Diagnostics - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Diagnostics - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Diagnostics - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Bayer AG - Overview
Exhibits86: Bayer AG - Business segments
Exhibits87: Bayer AG - Key offerings
Exhibits88: Bayer AG - Segment focus
Exhibits89: C. H. Boehringer Sohn AG and Co. KG - Overview
Exhibits90: C. H. Boehringer Sohn AG and Co. KG - Business segments
Exhibits91: C. H. Boehringer Sohn AG and Co. KG - Key news
Exhibits92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
Exhibits93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
Exhibits94: Ceva Sante Animale - Overview
Exhibits95: Ceva Sante Animale - Product / Service
Exhibits96: Ceva Sante Animale - Key offerings
Exhibits97: Dechra Pharmaceuticals Plc - Overview
Exhibits98: Dechra Pharmaceuticals Plc - Business segments
Exhibits99: Dechra Pharmaceuticals Plc - Key offerings
Exhibits100: Dechra Pharmaceuticals Plc - Segment focus
Exhibits101: Heska Corp. - Overview
Exhibits102: Heska Corp. - Business segments
Exhibits103: Heska Corp. - Key news
Exhibits104: Heska Corp. - Key offerings
Exhibits105: Heska Corp. - Segment focus
Exhibits106: IDEXX Laboratories Inc. - Overview
Exhibits107: IDEXX Laboratories Inc. - Business segments
Exhibits108: IDEXX Laboratories Inc. - Key news
Exhibits109: IDEXX Laboratories Inc. - Key offerings
Exhibits110: IDEXX Laboratories Inc. - Segment focus
Exhibits111: Indian Immunologicals Ltd. - Overview
Exhibits112: Indian Immunologicals Ltd. - Product / Service
Exhibits113: Indian Immunologicals Ltd. - Key offerings
Exhibits114: Merck and Co. Inc. - Overview
Exhibits115: Merck and Co. Inc. - Business segments
Exhibits116: Merck and Co. Inc. - Key news
Exhibits117: Merck and Co. Inc. - Key offerings
Exhibits118: Merck and Co. Inc. - Segment focus
Exhibits119: Virbac Group - Overview
Exhibits120: Virbac Group - Business segments
Exhibits121: Virbac Group - Key news
Exhibits122: Virbac Group - Key offerings
Exhibits123: Virbac Group - Segment focus
Exhibits124: Zoetis Inc. - Overview
Exhibits125: Zoetis Inc. - Business segments
Exhibits126: Zoetis Inc. - Key news
Exhibits127: Zoetis Inc. - Key offerings
Exhibits128: Zoetis Inc. - Segment focus
Exhibits129: Inclusions checklist
Exhibits130: Exclusions checklist
Exhibits131: Currency conversion rates for US$
Exhibits132: Research methodology
Exhibits133: Validation techniques employed for market sizing
Exhibits134: Information sources
Exhibits135: List of abbreviations